» Articles » PMID: 23066164

Myeloperoxidase: a Front-line Defender Against Phagocytosed Microorganisms

Overview
Journal J Leukoc Biol
Date 2012 Oct 16
PMID 23066164
Citations 250
Authors
Affiliations
Soon will be listed here.
Abstract

Successful immune defense requires integration of multiple effector systems to match the diverse virulence properties that members of the microbial world might express as they initiate and promote infection. Human neutrophils--the first cellular responders to invading microbes--exert most of their antimicrobial activity in phagosomes, specialized membrane-bound intracellular compartments formed by ingestion of microorganisms. The toxins generated de novo by the phagocyte NADPH oxidase and delivered by fusion of neutrophil granules with nascent phagosomes create conditions that kill and degrade ingested microbes. Antimicrobial activity reflects multiple and complex synergies among the phagosomal contents, and optimal action relies on oxidants generated in the presence of MPO. The absence of life-threatening infectious complications in individuals with MPO deficiency is frequently offered as evidence that the MPO oxidant system is ancillary rather than essential for neutrophil-mediated antimicrobial activity. However, that argument fails to consider observations from humans and KO mice that demonstrate that microbial killing by MPO-deficient cells is less efficient than that of normal neutrophils. We present evidence in support of MPO as a major arm of oxidative killing by neutrophils and propose that the essential contribution of MPO to normal innate host defense is manifest only when exposure to pathogens overwhelms the capacity of other host defense mechanisms.

Citing Articles

Determination of the Inhibitory Potential of Chalcones on Myeloperoxidase Enzyme Activity: In vitro and Molecular Docking Studies.

Abul N, Demir Y, Oztekin A, Ozdemir H Cell Biochem Biophys. 2025; .

PMID: 40080351 DOI: 10.1007/s12013-025-01719-0.


accelerates methicillin-resistant eradication by promoting migration and activation of neutrophils.

Dong S, Bai X, Chen B, Fan M, Liu Q, Zhao Y Front Pharmacol. 2025; 15:1501744.

PMID: 39877391 PMC: 11772359. DOI: 10.3389/fphar.2024.1501744.


Identification of Protein Networks and Biological Pathways Driving the Progression of Atherosclerosis in Human Carotid Arteries Through Mass Spectrometry-Based Proteomics.

Kallo G, Zaman K, Potor L, Hendrik Z, Mehes G, Toth C Int J Mol Sci. 2025; 25(24.

PMID: 39769427 PMC: 11728284. DOI: 10.3390/ijms252413665.


Tumor cell membrane-based vaccines: A potential boost for cancer immunotherapy.

Yang M, Zhou J, Lu L, Deng D, Huang J, Tang Z Exploration (Beijing). 2024; 4(6):20230171.

PMID: 39713208 PMC: 11655317. DOI: 10.1002/EXP.20230171.


Environment-sensitive turn-on fluorescent probe enables live cell imaging of myeloperoxidase activity during NETosis.

Ramos Caceres E, Kemperman L, Bonger K Commun Chem. 2024; 7(1):262.

PMID: 39533026 PMC: 11557929. DOI: 10.1038/s42004-024-01338-5.


References
1.
Shafer W, Onunka V, Martin L . Antigonococcal activity of human neutrophil cathepsin G. Infect Immun. 1986; 54(1):184-8. PMC: 260134. DOI: 10.1128/iai.54.1.184-188.1986. View

2.
Grisham M, Jefferson M, Melton D, Thomas E . Chlorination of endogenous amines by isolated neutrophils. Ammonia-dependent bactericidal, cytotoxic, and cytolytic activities of the chloramines. J Biol Chem. 1984; 259(16):10404-13. View

3.
Tiden A, Sjogren T, Svensson M, Bernlind A, Senthilmohan R, Auchere F . 2-thioxanthines are mechanism-based inactivators of myeloperoxidase that block oxidative stress during inflammation. J Biol Chem. 2011; 286(43):37578-89. PMC: 3199503. DOI: 10.1074/jbc.M111.266981. View

4.
Odeberg H, Olsson I . Microbicidal mechanisms of human granulocytes: synergistic effects of granulocyte elastase and myeloperoxidase or chymotrypsin-like cationic protein. Infect Immun. 1976; 14(6):1276-83. PMC: 415527. DOI: 10.1128/iai.14.6.1276-1283.1976. View

5.
McCall T, Feelisch M, Palmer R, Moncada S . Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. Br J Pharmacol. 1991; 102(1):234-8. PMC: 1917886. DOI: 10.1111/j.1476-5381.1991.tb12159.x. View